SeaSpine Holdings Corporation (SPNE)

NASDAQ: SPNE · IEX Real-Time Price · USD
5.64
-0.08 (-1.40%)
Sep 27, 2022 4:00 PM EDT - Market closed
-1.40%
Market Cap 209.74M
Revenue (ttm) 209.05M
Net Income (ttm) -66.96M
Shares Out 37.19M
EPS (ttm) -1.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 83,193
Open 5.74
Previous Close 5.72
Day's Range 5.50 - 5.84
52-Week Range 5.50 - 16.65
Beta 1.34
Analysts Buy
Price Target 18.65 (+230.7%)
Earnings Date Oct 26, 2022

About SPNE

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone pro... [Read more...]

Industry Health Care Equipment & Supplies
CEO Keith Valentine
Employees 523
Stock Exchange NASDAQ
Ticker Symbol SPNE
Full Company Profile

Financial Performance

In 2021, SPNE's revenue was $191.45 million, an increase of 24.04% compared to the previous year's $154.35 million. Losses were -$54.35 million, 25.9% more than in 2020.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for SPNE stock is "Buy." The 12-month stock price forecast is 18.65, which is an increase of 230.67% from the latest price.

Price Target
$18.65
(230.67% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference

CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

1 week ago - GlobeNewsWire

SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System

CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

3 weeks ago - GlobeNewsWire

SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

1 month ago - GlobeNewsWire

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -8.57% and 3.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Re...

CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

1 month ago - GlobeNewsWire

SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

SeaSpine to Report Second Quarter 2022 Financial Results on August 2, 2022

CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

2 months ago - GlobeNewsWire

SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility

Provides for up to an additional $10 million of liquidity Provides for up to an additional $10 million of liquidity

2 months ago - GlobeNewsWire

3 Amazing Stocks Under $10

Here's why we like SeaSpine, Recursion Pharmaceuticals, and Agenus.

Other symbols: AGENRXRX
2 months ago - The Motley Fool

SeaSpine® Announces Full Commercial Launch of WaveForm® C 3D-printed Interbody System

Company's second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million cervical market opportunity Company's second fully ...

3 months ago - GlobeNewsWire

SeaSpine Announces Full Commercial Launch of the WaveForm™ TO (TLIF Oblique) 3D-Printed Interbody System

Company's first full commercial launch of novel 3D printed interbody product franchise that addresses estimated $500 million market opportunity Company's first full commercial launch of novel 3D printed...

3 months ago - GlobeNewsWire

3 Med-Tech Stocks With Incredible Potential

Here's why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.

Other symbols: IRTCOWLT
3 months ago - The Motley Fool

SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -28.57% and 3.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance

CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

4 months ago - GlobeNewsWire

SeaSpine® Announces New Senior Leadership Team Appointments

CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

4 months ago - GlobeNewsWire

SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families

CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

4 months ago - GlobeNewsWire

Will SeaSpine Holdings (SPNE) Report Negative Earnings Next Week? What You Should Know

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

SeaSpine (SPNE) Moves 5.8% Higher: Will This Strength Last?

SeaSpine (SPNE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

5 months ago - Zacks Investment Research

SeaSpine to Report First Quarter 2022 Financial Results on May 3, 2022

CARLSBAD, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

5 months ago - GlobeNewsWire

SeaSpine Announces Full Commercial Launch of the Reef® TA (TLIF Articulating) Interbody System

CARLSBAD, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

5 months ago - GlobeNewsWire

SeaSpine® Announces 50,000th NanoMetalene® Implantation

CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

6 months ago - GlobeNewsWire

SeaSpine to Participate in the Canaccord Musculoskeletal Conference

CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

6 months ago - GlobeNewsWire

SeaSpine Holdings (SPNE) Reports Q4 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -44.44% and 1.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results

Provides 2022 Revenue Guidance Provides 2022 Revenue Guidance

6 months ago - GlobeNewsWire

SeaSpine to Host Virtual Analyst and Investor Day on March 11, 2022

Announces Date of Fourth Quarter and Full Year 2021 Financial Results Conference Call Announces Date of Fourth Quarter and Full Year 2021 Financial Results Conference Call

7 months ago - GlobeNewsWire